Skip to main content
Fig. 10 | BMC Medical Genomics

Fig. 10

From: BNIPL is a promising biomarker of laryngeal cancer: novel insights from bioinformatics analysis and experimental validation

Fig. 10

BNIPL inhibits the viability, migration, and invasion of TU212 and TU686 cells. (A) The transfection efficiency of BNIPL was detected by western blot. (B) The cell viability of TU212 and TU686 cells was evaluated by Cell Counting Kit-8. (C) The migration of TU212 and TU686 cells was assessed by wound-healing assay. (D) The invasion of TU212 and TU686 cells was measured by transwell assay. (Amplification: 200×, Scale: 100 μm). ***P < 0.001 vs. pcDNA3.1-NC group, (n = 3)

Back to article page

BMC Medical Genomics

ISSN: 1755-8794

Contact us